Neoadjuvant chemoradiotherapy in gallbladder cancer;Quimiorradioterapia de neoadyuvancia en cáncer de vesÍcula biliar

Revista Medica de Chile

Volumn 132, Issue 1, 2004, Pages 51-57

  De Aretxabala U, Xabier ^a,b   Losada M, Héctor ^a,b   Mora P, Javier ^b   Roa E, Iván ^b   Burgos S, Luis ^a,b   Yáñez R, Eduardo ^b   Quijada P, Ingrid ^b   Roa S, Juan Carlos ^b  

^a Hospital Regional de Temuco   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

Adjuvant; Chemotherapy; Gallbladder neoplasms; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BILIARY TRACT SURGERY; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HEMATOLOGIC DISEASE; HUMAN; LEUKOPENIA; LIVER METASTASIS; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RADIATION DOSE; SEROSA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; GALLBLADDER NEOPLASMS; HUMANS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12544253221     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. DE ARETXABALA X, ROA I, BURGOS L. Cáncer de la vesícula biliar. Algunas consideraciones. Rev Méd Chile 1996; 124: 732-9.
2. DE ARETXABALA X, ROA I, BURGOS L, ARAYA JC, FONSECA L, WISTUBA I ET AL. Gallbladder cancer in Chile. A report on 54 potentially resectable tumors. Cancer 1992; 69: 60-5.
3. DE ARETXABALA X, ROA I, BURGOS L, ARAYA JC, VILLASECA MA, SILVA J. Curative resection in potentially resectable tumors of the gallbladder. Eur J Sur 1997; 163: 419-26.
4. SHIRAI Y, YOSHIDA K, TSUKADA K, MUTO T. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 1992; 215: 326-31.
5. OUCHI K, SUZUKI M, SAIJO S, ITO K, MATSUNO S. Do recent advances in diagnosis and operative management improve the outcome of gallbladder carcinoma? Surgery 1993; 113: 324-9.
6. DONOHUE JH, GRANT CS, TSUSSHIMA K, ILSTRUP DM, ADSON M. Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg 1990; 125: 237-41.
7. GAGNER M, ROSSI R. Radical operations for carcinoma of the gallbladder. Present status in North America. World J Surg 1991; 15: 344-7.
8. CHIJHWA K, TANAKA M. Carcinoma of the gallbladder: An appraisal of surgical resection. Surgery 1994; 115: 751-6.
9. DE ARETXABALA X, ROA I, BURGOS L, CARTES F, SILVA J, YÁÑEZ E ET AL. Preoperative chemoradiotherapy in the treatment of gallbladder cancer. Am Surg 1999; 65: 241-6.
10. OKEN MM, CREECH RH, TORMEY DC, HORTON J, DAVIS TE, MCFADDEN ET ET AL. Toxicity and response Criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55.
11. NERVI F. Cancer of the gallbladder in Chile. Rev Méd Chile 2001; 129: 979-81.
12. EVANS DB, RICH TA. Preoperative chemoradiation and pancreatoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992; 127: 1335-9.
13. RICH TA, EVANS DB. Preoperative combined modality therapy for pancreatic cancer. World J Surg 1995; 19: 264-9.
14. LOWY AM, MANSFIELD PF, LEACH SD, PAZDUR R, DUMAS P, AJANI JA. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg 1999; 229: 303-8.
15. JESSUP JM, STEELE JR, MAYER RJ, POSNER M, BUSSE P, CADY B. Neoadyuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993; 28: 559-64.
16. TSUJI A. Preliminary clinical evaluation of low-dose CDDP and continuous 5-FU therapy for advanced gallbladder cancer. Gan To Kagaku Ryoho 2000; 27: 233-7.
17. KRESL JJ. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002; 52: 167-75.
18. SASSON AR. Trimodality therapy for advanced gallbladder cancer. Am Surg 2001; 67: 277-83.
19. CARMICHAEL J. Clinical response benefit in patients with advanced pancreatic cancer. Role of gemcitabine. Digestion 1997; 58: 503-7.
20. OKADA S. Phase I trial of gemcitabine in patients with advanced pancreatic cancer. Jpn J Clin Oncol 2001; 31: 7-12.
21. BURRIS HA, MOORE MJ, ANDERSEN J, GREEN MR, ROTHENBERG ML, MODIANO MR ET AL. Improvements in survival and clinical benefit with gemcitabine as first line therapy in patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-13.
22. CASTRO M. Efficacy of gemcitabine in the treatment of patients with gallbladder carcinoma. Cancer 1998; 83: 2419-20.
23. GALLARDO, RUBIO B, FODOR M, ORLANDO L, YÁÑEZ M, GAMARGO C ET AL. A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol 2001; 12: 1403-6.